Extrahepatic Bile Duct Neoplasm

subtype

Identifier: CI-CAN-00002645
Entity page: /cancer/extrahepatic-bile-duct-neoplasm ↗
Edges: 213

Neighbours: 15 drugs10 trials
Drawn: 25 of 25 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Extrahepatic Bile Duct Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 51show all (up to 200)
→ investigated in trials for	Gemcitabinesmall molecule 29 trials (5 active) · roll-up of the cancer and its descendants	—	—	Extrahepatic Bile Duct Neoplasm	29	Observed	clinicaltrials	graph →
→ investigated in trials for	Cisplatin

Extrahepatic Bile Duct Neoplasm studied in …STUDIED_INderived10 of 162show all (up to 200)
→ studied in	NCT05712356Phase 2 · completed A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 162 trials mapped (37 active)	—	—	Extrahepatic Cholangiocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02293954NA · active not recruiting Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer · condition mapped ALIAS · 162 trials mapped (37 active)	—	—	Malignant Extrahepatic Bile Duct Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT07161869recruiting Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III) · condition mapped ONTOLOGY_EXACT · 162 trials mapped (37 active)	—	—	Hilar Cholangiocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07780838Phase 2 · recruiting Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma · condition mapped CURATED_BROADER · 162 trials mapped (37 active)	—	—	Extrahepatic Cholangiocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06175845NA · recruiting Endoscopic Radiofrequency Ablation for Unresectable Cholangiocarcinoma · condition mapped ALIAS · 162 trials mapped (37 active)	—	—	Hilar Cholangiocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07796997Phase 1 · not yet recruiting GI-06: The Impact of Perioperative Hydrocortisone on Patients Undergoing Partial Pancreatectomy · condition mapped ONTOLOGY_EXACT · 162 trials mapped (37 active)	—	—	Distal Cholangiocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07793253Phase 2 · not yet recruiting Phase 2 Study of Daraxonrasib in Recurrent KRAS-Mutant Biliary Tract Cancer · condition mapped ONTOLOGY_EXACT · 162 trials mapped (37 active)	—	—	Extrahepatic Cholangiocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06923475Phase 2/Phase 3 · recruiting Neoadjuvant Gemcitabine and Cisplatin in Combination With Perioperative Pembrolizumab Versus Upfront Surgery for Patients With Primary Resectable and Borderline Resectable Perihilar and Distal Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 162 trials mapped (37 active)	—	—	Extrahepatic Cholangiocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07765433Phase 2/Phase 3 · not yet recruiting Testing the Addition of Ivonescimab Combined With Standard Chemotherapy Compared to the Usual Chemotherapy and Immunotherapy Treatment for Patients With Advanced Biliary Tract Cancer · condition mapped CURATED_BROADER · 162 trials mapped (37 active)	—	—	Extrahepatic Cholangiocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05564403Phase 2 · active not recruiting Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial) · condition mapped CURATED_BROADER · 162 trials mapped (37 active)	—	—	Hilar Cholangiocarcinoma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains